ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,652, issued on Nov. 25, was assigned to Ferring B.V. (Hoofddorp, Netherlands) and Institut Pasteur (Paris).
"Bacteriophage therapy" was invented by Pascal Danglas (Saint-Prex, Switzerland) and Laurent Debarbieux (Paris).
According to the abstract* released by the U.S. Patent & Trademark Office: "The subject invention provides a pharmaceutical composition comprising: (i) at least one bacteriophage strain(s) capable of producing a lytic infection in an adherent-invasive Escherichia coli strain; and (ii) a pharmaceutically acceptable carrier; for the treatment of inflammatory bowel disease.The subject invention further provides a method of treating inflammatory bowel disease compris...